EMA And HMA Speak Out In Favor Of Biosimilar Interchangeability

All Biosimilars Can Be Substituted In EU With Member States’ Consent

 
• By Chloe Kent

Stakeholders in Europe have been hesitant to allow interchangeable substitution of biological products, prompting the European Medicines Agency to clarify its stance on the issue.

Pharmacist speaking to patient at counter
Biosimilar interchangeability has a notably different meaning in the US compared to the EU • Source: Shutterstock

More from Biosimilars

More from Products